Revised forecast
Fiscal year ending July 2026 · Full yearPrevious forecast published 12 June 2026The bar length represents the relative magnitude of change, based on the item that changed the most in this document.
The development and commercialization of the new IBIS2 C product took longer than expected, and the product launch began on 24 July 2026, limiting the sales period. As a result, its expected contribution to sales was not realized. Profit differed from the forecast due to the impact of the sales shortfall, as well as the recognition of non-operating income and other factors.
| Item | Details |
|---|---|
| Net Sales | 1,700～1,900 → ¥1,595 million（△6.2～△16.1） |
| Operating profit | △2,154～△2,311 → △2,397 |
| Ordinary income | △574～△730 → △807 |
| Profit attributable to owners of the parent | △575～△731 → △811 |
| Net income per share | △¥30.26–△¥38.47 → -¥42.27 |
| Fiscal Period Covered | Fiscal year ending July 2026 |
| Period Covered | Full year |
| Publication date of previous forecast | 12 June 2026 |
| Previous-period results | Sales of ¥1,406 million, an operating loss of ¥1,588 million, ordinary income of ¥46 million, net income attributable to owners of the parent of ¥46 million, and earnings per share of ¥2.44 |
| Reason for the revision | The development and commercialization of the new IBIS2 C product took longer than expected, and the product launch began on 24 July 2026, limiting the sales period. As a result, its expected contribution to sales was not realized. Profit differed from the forecast due to the impact of the sales shortfall, as well as the recognition of non-operating income and other factors. |
| Consolidated / non-consolidated | Consolidated |
Items this document does not state (2)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The development and commercialization of the new IBIS2 C product took longer than initially expected, and the product launch began on 24 July 2026. As a result, the product's sales period during the fiscal year was limited, and its expected contribution to sales was not realized. Profit differed from the forecast due to the impact of the sales shortfall, as well as the recognition of non-operating income and other factors. The Company recorded an equity-method investment gain of ¥48.721 million and subsidy income of ¥35.632 million as non-operating income.